1,2-dimethylhydrazine decreases expression ISO Arhgap5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ARHGAP5 mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of ARHGAP5 mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ARHGAP5 mRNA CTD PMID:29097150 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ARHGAP5 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARHGAP5 mRNA and Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA] CTD PMID:16054899 and PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGAP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARHGAP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Arhgap5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGAP5 mRNA CTD PMID:18691609 and PMID:24680724 2,4,6-tribromophenol decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ARHGAP5 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ARHGAP5 mRNA CTD PMID:30423314 and PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of ARHGAP5 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine decreases expression ISO Arhgap5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ARHGAP5 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA more ... CTD PMID:16054899 4-hydroxynon-2-enal decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 4-hydroxy-2-nonenal results in decreased expression of ARHGAP5 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression ISO Arhgap5 (Mus musculus) 6480464 Fenretinide results in decreased expression of ARHGAP5 mRNA CTD PMID:28973697 4-vinylcyclohexene dioxide affects expression ISO Arhgap5 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of ARHGAP5 mRNA CTD PMID:20829426 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ARHGAP5 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of ARHGAP5 mRNA CTD PMID:28959563 acrylamide increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Acrylamide results in increased expression of ARHGAP5 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO ARHGAP5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ARHGAP5 gene CTD PMID:27153756 aflatoxin M1 decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of ARHGAP5 mRNA CTD PMID:30928695 antirheumatic drug decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ARHGAP5 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ARHGAP5 mRNA CTD PMID:33212167 arsenous acid increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARHGAP5 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO Arhgap5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ARHGAP5 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression ISO Arhgap5 (Mus musculus) 6480464 bisphenol A results in increased expression of ARHGAP5 mRNA CTD PMID:26063408 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARHGAP5 mRNA CTD PMID:32145629 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARHGAP5 mRNA CTD PMID:30816183 and PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARHGAP5 mRNA CTD PMID:25181051 and PMID:33296240 cadmium atom multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP5 mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of ARHGAP5 mRNA CTD PMID:12160620 cadmium dichloride multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP5 mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO Arhgap5 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of ARHGAP5 mRNA CTD PMID:24982889 caffeine affects phosphorylation ISO ARHGAP5 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of ARHGAP5 protein CTD PMID:35688186 calcitriol increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Calcitriol results in increased expression of ARHGAP5 mRNA CTD PMID:16002434 cantharidin increases expression ISO Arhgap5 (Mus musculus) 6480464 Cantharidin results in increased expression of ARHGAP5 mRNA CTD PMID:36907384 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of ARHGAP5 mRNA CTD PMID:23125180 cisplatin increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Cisplatin results in increased expression of ARHGAP5 mRNA CTD PMID:27594783 cisplatin decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ARHGAP5 mRNA CTD PMID:27392435 clobetasol decreases expression ISO Arhgap5 (Mus musculus) 6480464 Clobetasol results in decreased expression of ARHGAP5 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGAP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGAP5 mRNA] CTD PMID:17585979 cocaine increases expression EXP 6480464 Cocaine results in increased expression of ARHGAP5 mRNA CTD PMID:17898221 copper(II) sulfate increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ARHGAP5 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO ARHGAP5 (Homo sapiens) 6480464 coumarin affects the phosphorylation of ARHGAP5 protein CTD PMID:35688186 cyclosporin A decreases expression ISO Arhgap5 (Mus musculus) 6480464 Cyclosporine results in decreased expression of ARHGAP5 mRNA CTD PMID:19770486 DDT decreases expression EXP 6480464 DDT results in decreased expression of ARHGAP5 mRNA CTD PMID:30207508 decabromodiphenyl ether decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of ARHGAP5 protein CTD PMID:31675489 dexamethasone multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA more ... CTD PMID:16054899 diarsenic trioxide increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ARHGAP5 mRNA CTD PMID:20458559 diazinon increases methylation ISO ARHGAP5 (Homo sapiens) 6480464 Diazinon results in increased methylation of ARHGAP5 gene CTD PMID:22964155 dicrotophos decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of ARHGAP5 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ARHGAP5 mRNA CTD PMID:29803840 entinostat multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP5 mRNA CTD PMID:27188386 entinostat decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 entinostat results in decreased expression of ARHGAP5 mRNA CTD PMID:26272509 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ARHGAP5 protein CTD PMID:20829428 ethanol multiple interactions ISO Arhgap5 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of ARHGAP5 mRNA CTD PMID:30319688 ethanol increases expression ISO Arhgap5 (Mus musculus) 6480464 Ethanol results in increased expression of ARHGAP5 mRNA CTD PMID:30319688 ethanol decreases expression ISO Arhgap5 (Mus musculus) 6480464 Ethanol results in decreased expression of ARHGAP5 mRNA CTD PMID:29018328 ethyl methanesulfonate decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of ARHGAP5 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of ARHGAP5 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO ARHGAP5 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of ARHGAP5 protein CTD PMID:37730182 hydralazine multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP5 mRNA CTD PMID:17183730 irinotecan decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Irinotecan metabolite results in decreased expression of ARHGAP5 mRNA and Irinotecan results in decreased expression of ARHGAP5 mRNA CTD PMID:15956246 irinotecan increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Irinotecan metabolite results in increased expression of ARHGAP5 mRNA and Irinotecan results in increased expression of ARHGAP5 mRNA CTD PMID:15956246 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ARHGAP5 mRNA CTD PMID:20080153 lipopolysaccharide multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP5 mRNA CTD PMID:35811015 methidathion decreases expression ISO Arhgap5 (Mus musculus) 6480464 methidathion results in decreased expression of ARHGAP5 mRNA CTD PMID:34813904 methotrexate increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Methotrexate results in increased expression of ARHGAP5 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of ARHGAP5 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ARHGAP5 mRNA CTD PMID:23179753 more ... miconazole decreases expression ISO Arhgap5 (Mus musculus) 6480464 Miconazole results in decreased expression of ARHGAP5 mRNA CTD PMID:27462272 N-nitrosodiethylamine increases expression ISO Arhgap5 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of ARHGAP5 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO Arhgap5 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP5 mRNA] CTD PMID:17942915 nickel sulfate decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of ARHGAP5 mRNA CTD PMID:22714537 panobinostat decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 panobinostat results in decreased expression of ARHGAP5 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP5 mRNA CTD PMID:27188386 paracetamol multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ARHGAP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ARHGAP5 mRNA] CTD PMID:17585979 perfluorooctane-1-sulfonic acid decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of ARHGAP5 mRNA CTD PMID:27153767 phenobarbital affects expression ISO ARHGAP5 (Homo sapiens) 6480464 Phenobarbital affects the expression of ARHGAP5 mRNA CTD PMID:19159669 phenobarbital decreases expression ISO Arhgap5 (Mus musculus) 6480464 Phenobarbital results in decreased expression of ARHGAP5 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO Arhgap5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of ARHGAP5 mRNA CTD PMID:18445702 pirinixic acid multiple interactions ISO Arhgap5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARHGAP5 mRNA CTD PMID:19710929 rac-lactic acid increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ARHGAP5 mRNA CTD PMID:30423314 and PMID:30851411 resveratrol decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 resveratrol results in decreased expression of ARHGAP5 mRNA and resveratrol results in decreased expression of ARHGAP5 protein CTD PMID:18089832 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP5 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO Arhgap5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of ARHGAP5 mRNA CTD PMID:19073995 silver atom decreases expression ISO Arhgap5 (Mus musculus) 6480464 Silver results in decreased expression of ARHGAP5 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Arhgap5 (Mus musculus) 6480464 Silver results in decreased expression of ARHGAP5 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ARHGAP5 mRNA CTD PMID:12760830 sodium arsenite increases expression ISO Arhgap5 (Mus musculus) 6480464 sodium arsenite results in increased expression of ARHGAP5 mRNA CTD PMID:16322246 sodium fluoride decreases expression ISO Arhgap5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of ARHGAP5 mRNA CTD PMID:27862939 sunitinib increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Sunitinib results in increased expression of ARHGAP5 mRNA CTD PMID:31533062 tetrachloroethene increases expression ISO Arhgap5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of ARHGAP5 mRNA CTD PMID:28973375 thimerosal increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Thimerosal results in increased expression of ARHGAP5 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of ARHGAP5 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP5 mRNA CTD PMID:27188386 triptonide decreases expression ISO Arhgap5 (Mus musculus) 6480464 triptonide results in decreased expression of ARHGAP5 mRNA CTD PMID:33045310 urethane increases expression ISO ARHGAP5 (Homo sapiens) 6480464 Urethane results in increased expression of ARHGAP5 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO ARHGAP5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP5 mRNA more ... CTD PMID:17183730 and PMID:27188386 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ARHGAP5 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ARHGAP5 mRNA CTD PMID:29427782 valproic acid decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ARHGAP5 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO ARHGAP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of ARHGAP5 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ARHGAP5 mRNA CTD PMID:19015723 vincristine decreases expression ISO ARHGAP5 (Homo sapiens) 6480464 Vincristine results in decreased expression of ARHGAP5 mRNA CTD PMID:23649840
